OGEN Stock Research Snapshot: Pipeline, Catalysts, and Cash Runway

Oragenics Inc | Needs refresh | Last updated: 2026-06-01T17:55:29Z

TickerOGEN

Market Cap2.8M

Cash RunwayRunway 6-12 months

Next Catalystn/a

Public Research Snapshot

Oragenics Inc is a publicly tracked healthcare company. This research snapshot summarizes public information on pipeline assets, clinical trials, upcoming catalysts, SEC filings, and cash runway estimates for ONP-002 in brain-related conditions (Approved).

Pipeline

Asset	Indication	Modality	Stage	Public Note
ONP-002	brain-related conditions	n/a	Approved	Public pipeline row
COVID-19	n/a	Vaccine	n/a	Public pipeline row
ProBiora3 mints	Oral Health	n/a	Na	Public pipeline row
AG013	Oral Mucositis	n/a	Phase 2	Public pipeline row
Neurosteroid enantiomer	Mild Traumatic Brain Injury, Concussion	n/a	Phase 2	Public pipeline row

Catalyst Preview

No public catalyst rows matched this view yet.

Cash Runway Preview

Estimated cash runway: Runway 6-12 months.

This is an automated estimate and may differ from company guidance.

Recent SEC Filings

No public filing rows are loaded yet.

Clinical Trial Activity

NCT ID	Phase	Status	Enrollment	Primary Completion
NCT01520974	Na	UNKNOWN	48	2012-08
NCT03234465	Phase 2	TERMINATED	200	2020-03-31
NCT06870240	Phase 2	NOT_YET_RECRUITING	40	2026-01-01

Scientific Context

literature_publication | The Interplay Among Pancreatic Cancer, Cachexia, Body Composition, and Diabetes.
literature_publication | Addressing unmet needs for people with cancer cachexia: recommendations from a multistakeholder workshop.
literature_publication | Cancer cachexia: the elephant in the room?
literature_publication | Percentile-based averaging and skeletal muscle gauge improve body composition analysis: validation at multiple vertebral levels.
literature_publication | Lipid II Binding and Transmembrane Properties of Various Antimicrobial Lanthipeptides.

Want the full OGEN research brief?

Subscribe for source-linked catalyst analysis, cash runway monitoring, and clinical trial change alerts.

Get the weekly biotech catalyst watchlist

This page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell securities. Data may be incomplete or delayed. Cash runway and catalyst timing estimates are derived from public sources and may differ from company guidance.